Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer

Prof Fabrice André - Institut Gustave Roussy, Paris, France
OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )
29 Sep 2020

ESMO 2020 melanoma roundup

Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
ESMO 2020 melanoma roundup ( Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany )
28 Sep 2020

OncoAlert and ecancer weekly roundup for September 20 - 26, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for September 20 - 26, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
28 Sep 2020

Nivolumab for oesophageal cancer following chemoradiation therapy

Dr Ronan Kelly - Charles A. Sammons Cancer Center, Dallas, USA
Nivolumab for oesophageal cancer following chemoradiation therapy ( Dr Ronan Kelly - Charles A. Sammons Cancer Center, Dallas, USA )
25 Sep 2020

PROFound trial and other recent updates in prostate cancer

Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
PROFound trial and other recent updates in prostate cancer ( Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Sep 2020

Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma

Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain
Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma ( Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain )
25 Sep 2020

Managing multiple myeloma in a COVID-19 world

Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
Managing multiple myeloma in a COVID-19 world ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )
25 Sep 2020

ESMO 2020 renal roundup

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ESMO 2020 renal roundup ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
25 Sep 2020

Exon 20 insertions in NSCLC - ESMO 2020

Dr Alex Spira, Prof Benjamin Besse, Prof Michael Thomas and Dr Antonio Passaro
Exon 20 insertions in NSCLC - ESMO 2020 ( Dr Alex Spira, Prof Benjamin Besse, Prof Michael Thomas and Dr Antonio Passaro )
25 Sep 2020

ESMO 2020: Lung cancer latest

Prof Solange Peters, Dr Federico Cappuzzo, Dr Antonio Passaro and Prof Sanjay Popat
ESMO 2020: Lung cancer latest ( Prof Solange Peters, Dr Federico Cappuzzo, Dr Antonio Passaro and Prof Sanjay Popat )
25 Sep 2020

Highlights from ESMO 2020

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ESMO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
25 Sep 2020

PARP inhibitors and their evolving role for the treatment of prostate cancer

Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
PARP inhibitors and their evolving role for the treatment of prostate cancer ( Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi )
24 Sep 2020